Abrdn PLC Adaptive Biotechnologies Corp Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Abrdn PLC holds 1,031,059 shares of ADPT stock, worth $12.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,031,059
Previous 1,197,622
13.91%
Holding current value
$12.9 Million
Previous $8.9 Million
34.99%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ADPT
# of Institutions
252Shares Held
151MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$376 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$164 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$140 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$83.3 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.79B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...